We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · June 18, 2020

Lower Risk for Severe Hypoglycemia With Insulin Glargine 300 U/mL vs Glargine 100 U/mL in Participants With Type 1 Diabetes

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Lower Risk for Severe Hypoglycaemia With Insulin Glargine 300 U/mL vs Glargine 100 U/mL in Participants With Type 1 Diabetes: A Meta-Analysis of 6-Month Phase 3 Clinical Trials
Diabetes Obes Metab 2020 Jun 09;[EPub Ahead of Print], T Danne, M Matsuhisa, C Sussebach, H Goyeau, F Lauand, E Niemoeller, GB Bolli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading